News | Cath Lab | August 22, 2016

DMC Heart Hospital Completes Complex High-Risk Indicated Interventional Procedure Course

Veteran interventional cardiologists and DMC Heart Hospital leadership offered four clinically complex PCI cases via live feed during the course

DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training

August 22, 2016 — The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course, utilizing an unprecedented four live, clinically complex cases. Participating physicians included: DMC Heart Hospital President Theodore Schreiber, M.D.; Vice President Cindy Grines, M.D.,; Medical Director of the Cardiac Care Unit and Chief of Cardiology Mahir Elder, M.D.; Cardiac Catheterization Lab Medical Director Amir Kaki, M.D.; and Tamam Mohamad, M.D.

The Complete Revascularization of Higher Risk Patients (frequently abbreviated as “CHIP”) program is geared toward the interventionalist seeking to better understand complex percutaneous coronary intervention (PCI) in the modern era. Presentations address treatment of left main disease, chronic total occlusions, long lesions, bifurcation lesions, “small vessels” and saphenous vein grafts. In addition, participants learn how to manage challenging patient subsets, such as those with advanced heart failure, as well as how to provide optimal hemodynamic support.

The course is a combination of live complex cases, hands-on workstations and didactic. DMC provided four live complex cases; traditionally, most accounts only do one or two live cases. The cases are displayed via live video feed from the cardiac catheterization lab to the education room.

This course educated interventional physicians on an option for patients that are too sick for surgery or refuse surgery. By training other interventional cardiologists on why, how and which patients are U.S. Food and Drug Administration (FDA)-indicated for supported PCI, more heart failure patients can be treated effectively, versus being sent home on medical management. Additionally, the data shows when treated by supported PCI, these patients stay in the hospital for a shorter periods of time, they feel better once they leave and they experience less readmissions.

“No other Complex PCI CHIP course has ever demonstrated four live cases as complex as the ones showcased on Monday,” according to Schreiber. “However, it is not only the case complexity and the positive outcomes achieved, but the ability to engage the audience with questions, knowledge, charm and even some humor, which makes this course an impactful and memorable experience for all.”

For more information: www.dmc.org

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init